Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Atogepant als preventieve behandeling van chronische migraine: PROGRESS
nov 2023 | Hoofdpijn